Week 2 General Receptor Pharmacology: Antagonism, Inverse Agonism, and Desensitization
General Receptor Pharmacology
Antagonism
Antagonists bind to receptors but do not activate them, preventing the action of agonists.
Types of antagonists:
Competitive antagonists: compete with agonists for the same binding site.
Non-competitive antagonists: bind to an alternative site and change receptor conformation.
Inverse Agonism
Inverse agonists reduce the activity of receptors below their baseline level.
Important for receptors that have constitutive (basal) activity.
Example: β-blockers act as inverse agonists at β-adrenoceptors.
Desensitization
Process by which a receptor becomes less responsive to stimulation.
Can be caused by prolonged exposure to agonists, leading to reduced receptor signaling.
Mechanisms:
Receptor phosphorylation leading to decreased affinity for agonists.
Internalization of receptors from the cell surface, reducing availability for agonists.
Agonism
Agonists bind to receptors and activate them, mimicking the action of endogenous substances.
Types of agonists:
Full agonists: activate receptors fully.
Partial agonists: activate receptors but with less efficacy than full agonists.
Biased agonists: preferentially activate specific signaling pathways.
Receptor Types
Ionotropic receptors: ligand-gated ion channels that mediate fast synaptic transmission.
Metabotropic receptors: receptors that activate intracellular signaling pathways through G-proteins.
Receptor Upregulation and Downregulation
Upregulation: increase in receptor numbers in response to low hormone levels or antagonists.
Downregulation: decrease in receptor numbers in response to high levels of a hormone or prolonged stimulation.
Pharmacodynamics
Study of the effects of drugs and their mechanisms of action.
Key concepts include dose-response relationships and therapeutic indices.
Important to understand drug efficacy vs. potency.
Drug-Drug Interactions
Synergistic effects: when two drugs work together to enhance their effects.
Antagonistic effects: when one drug opposes the action of another.
Important in clinical settings to avoid adverse outcomes.
Clinical Implications
Understanding receptor pharmacology is crucial for developing and administering effective medication.
Helps in predicting responses to drugs and potential side effects.
Antagonism
Antagonists bind to receptors but do not activate them, preventing the action of agonists.
Types of antagonists:
Competitive antagonists: compete with agonists for the same binding site.
Non-competitive antagonists: bind to an alternative site and change receptor conformation.
Inverse Agonism
Inverse agonists reduce the activity of receptors below their baseline level.
Important for receptors that have constitutive (basal) activity.
Example: β-blockers act as inverse agonists at β-adrenoceptors.
Desensitization
Process by which a receptor becomes less responsive to stimulation.
Can be caused by prolonged exposure to agonists, leading to reduced receptor signaling.
Mechanisms:
Receptor phosphorylation leading to decreased affinity for agonists.
Internalization of receptors from the cell surface, reducing availability for agonists.
Agonism
Agonists bind to receptors and activate them, mimicking the action of endogenous substances.
Types of agonists:
Full agonists: activate receptors fully.
Partial agonists: activate receptors but with less efficacy than full agonists.
Biased agonists: preferentially activate specific signaling pathways.
Receptor Types
Ionotropic receptors: ligand-gated ion channels that mediate fast synaptic transmission.
Metabotropic receptors: receptors that activate intracellular signaling pathways through G-proteins.
Receptor Upregulation and Downregulation
Upregulation: increase in receptor numbers in response to low hormone levels or antagonists.
Downregulation: decrease in receptor numbers in response to high levels of a hormone or prolonged stimulation.
Pharmacodynamics
Study of the effects of drugs and their mechanisms of action.
Key concepts include:
Dose-response relationships showing the relationship between drug dose and effect.
Therapeutic indices indicating the safety margin of a drug.
Important to understand the difference between drug efficacy (the maximum effect achievable) vs. potency (the amount of drug needed to produce a given effect).
Drug-Drug Interactions
Synergistic effects: when two drugs work together to enhance their effects, leading to a greater overall effect than either drug alone (e.g., combining two antihypertensives).
Antagonistic effects: when one drug opposes the action of another, which can reduce therapeutic effectiveness (e.g., using naloxone to counteract opioid overdose).
Important in clinical settings to avoid adverse outcomes and adjust dosing regimens.
Clinical Implications
Understanding receptor pharmacology is crucial for developing and administering effective medication.
Helps in predicting responses to drugs and potential side effects, allowing for personalized medicine approaches.
Emphasizes the significance of monitoring patients for efficacy and safety in drug therapy, particularly in polypharmacy situations.